The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors

British Journal of Pharmacology

Volumn 129, Issue 7, 2000, Pages 1289-1291

  Smart, D ^a   Jerman, J C ^a   Brough, S J ^a   Neville, W A ^b   Jewitt, F ^a   Porter, R A ^b  

^a Neuroscience Research   (United Kingdom)

^b Medicinal Chemistry   (United Kingdom)

Author keywords

Calcium; FLIPR; Hypocretin; Orexin

Indexed keywords

CALCIUM ION; OREXIN A; OREXIN B;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CHO CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0034105344     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703257     Document Type: Article

References (11)

1. Delecea, L., Kilduff, T.S., Peyron, C., Gao, X.B., Foye, P.E., Danielson, P.E., Fukuhara, C., Battenberg, E.L.F., Gautvik, V.T., Bartlett, F.S., Frankel, W.N., Van Den Pol, A.N., Bloom, F.E., Gautvik, K.M. & Sutcliffe, J.G. (1998). The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U.S.A., 95, 322-327.
2. Flier, J.S. & Maratos-Flier, E. (1998). Obesity and the hypothalamus: novel peptides for new pathways. Cell, 92, 437-440.
3. Lohse, M.J. (1993). Molecular mechanisms of membrane receptor desensitization. Biochim. Biophys. Acta, 1179, 171-188.
4. Peyron, C., Tighe, D.K., Van Den Pol, A.N., Delecea, L., Heller, H.C., Sutcliffe, J.G. & Kilduff, T.S. (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci., 18, 9996-10015.
5. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H., Williams, S.C., Richardson, J.A., Kozlowski, G.P., Wilson, S., Arch, J.R.S., Buckinham, R.C., Haynes, A.C., Carr, S.A., Annan, R.S., McNulty, D.E., Liu, W.S., Terrett, J.A., Elshourbagy, N.A., Bergsma, D.J. & Yangisawa, M. (1998). Orexins and orexin receptors: a family of hypothelamic neuropeptides and G-protein coupled receptors that regulate feeding behaviour. Cell, 92, 573-585.
6. Samson, W.K., Gosnell, B., Chang, J.-K., Resch, Z.T. & Murphy, T.C. (1999). Cardiovascular regulatory actions of the hypocretins in brain. Brain Res., 31, 248-253.
7. Smart, D. (1999). Orexins: a new family of neuropeptides. Br. J. Anaesthes., 83, 695-697.
8. Smart, D., Jerman, J.C., Brough, S.J., Rushton, S.L., Murdock, P.R., Jewitt, F., Elshourbagy, N.A., Ellis, C.E., Middlemiss, D.N. & Brown, F. (1999). Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR. Br. J. Pharmacol., 128, 1-4.
9. i using the fluometric imaging plate reader (FLIPR). In: Lambert, D.G. (ed.). Calcium Signaling Protocols New Jersey: Humana Press, pp. 125-136.
10. Van Den Pol, A.N. (1999). Hypocretin (orexin): robust innervation of the rat spinal cord. J. Neurosci., 19, 3171-3182.
11. Van Den Pol, A.N., Gao, X.B., Obrietan, K., Kilduff, T.S. & Belousov, A.B. (1998). Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J. Neurosci., 18, 7962-7971.